Treatment results and outcomes vary among patients. Newer treatment therapies, progress in stem cell transplantation, better supportive care and studies of new drugs in clinical trials are all contributing to improved outcomes and quality of life for people diagnosed with blood cancers.
Many Hodgkin lymphoma patients are cured after their initial treatment. For the smaller number of patients who have disease recurrence or relapse, additional treatment with chemotherapy, sometimes combined with stem cell transplantation, is often successful. A large number of these patients are cured or have long disease-free periods.
Click here to access Hodgkin lymphoma survival statistics.
Treatment outcomes (prognosis) for the disease in its advanced stages are influenced by seven factors, known as the International Prognostic Factors for Advanced Hodgkin Lymphoma. Doctors use these factors to help them decide how aggressive treatment should be.
Higher risk is associated with these factors - the more factors present, the higher the risk. The patient's risk increases if the patient:
- Is male
- Is 45 years or older
- Has stage IV disease
- Has hemoglobin levels in the blood of less than 10.5 grams per deciliter (g/dL)
- Has a white cell count of 15,000 micrometers per liter (µL) or higher
- Has a lymphocyte (a type of white cell) count of less than 600/µL and/or less than 8 percent of the total white cell count
- Has albumin (a blood protein) levels of less than 4 g/dL
- Download or order The Leukemia & Lymphoma Society's free booklet, Hodgkin Lymphoma.